Quarterly report [Sections 13 or 15(d)]
Cover
Document and Entity Information
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Pay vs Performance Disclosure
Insider Trading Arrangements
Nature of Business
Liquidity
Basis of Presentation and Significant Accounting Policies
Fair Value of Financial Instruments
Marketable Securities
Equipment and Improvements
Supplemental Condensed Consolidated Balance Sheet Information
ATM Program/Open Market Sales Agreement
Stockholders' Equity
Acquisition of CorHepta
ABLi License Agreement
Stock-Based Compensation
Warrants
Net Loss Per Share
Income Taxes
Commitments and Contingencies
Segment Information
Accounting Policies
Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Basis of Presentation and Significant Accounting Policies (Tables)
Fair Value of Financial Instruments (Tables)
Marketable Securities (Tables)
Supplemental Condensed Consolidated Balance Sheet Information (Tables)
Acquisition of CorHepta (Tables)
Stock-Based Compensation (Tables)
Net Loss Per Share (Tables)
Commitments and Contingencies (Tables)
Segment Information (Tables)
Notes Details
Liquidity - Additional Information (Details)
Basis of Presentation and Significant Accounting Policies - Additional Information (Details)
Basis of Presentation and Significant Accounting Policies - classified as fixed assets useful life (Details)
Fair Value of Financial Instruments - Summary of cash equivalents and marketable securities measured at their fair value (Details)
Fair Value of Financial Instruments - Summary of contingent consideration related to acquisition (Details)
Marketable Securities - Summary of Marketable Securities (Details)
Marketable securities Additional Information (Details)
Equipment and Improvements Additional Information (Details)
Supplemental Condensed Consolidated Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)
ATM Program Additional Information (Details)
Notes Payable - Additional Information (Details)
ATM Program/Open Market Sales Agreement (Additional Information) (Details)
Stockholders' Equity - Additional Information (Details)
Acquisition of CorHepta (Additional Information) (Details)
Acquisition of CorHepta - Schedule of Fair Value of Consideration Transferred (Details)
Acquisition of CorHepta - Schedule of Allocation of Consideration Transferred (Details)
ABLi License Agreement (Additional Information) (Details)
Stock-based Compensation - Additional Information (Details)
Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees (Details)
Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees (Parenthetical) (Details)
Warrants - Additional Information (Details)
Net Loss Per Share - Summary of Calculation of Basic and Diluted Net Loss Per Share applicable to Common Stockholders (Details)
Net Loss Per Share (Additional Information) (Details)
Net Loss Per Share - Summary of Shares Excluded from Calculation of Diluted Net Loss per Share Applicable to Common Stockholders (Details)
Income Taxes - Additional Information (Details)
Commitments and Contingencies (Additional Information) (Details)
Commitments and Contingencies - Estimated Contractual Commitments Under Agreements (Details)
Commitments and Contingencies - Estimated Contractual Commitments Agreements (Parenthetical) (Details)
Correction of Prior Period Immaterial Error - Schedule of Error Corrections and Prior Period Adjustments (Details)
Segment Information (Additional Information) (Details)
Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Details)
Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Parenthetical) (Details)
Fair Value of Financial Instruments - Summary of cash equivalents and marketable securities measured at their fair value (Details)
403 Forbidden
Forbidden
You don't have permission to access this resource.